Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Down - Should You Sell?

Curaleaf logo with Medical background

Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $1.24, but opened at $1.20. Curaleaf shares last traded at $1.21, with a volume of 333,782 shares changing hands.

Curaleaf Trading Up 1.6%

The firm has a market cap of $851.47 million, a PE ratio of -4.10 and a beta of 0.62. The company has a debt-to-equity ratio of 1.08, a current ratio of 1.41 and a quick ratio of 0.70. The business has a 50-day moving average price of $0.90 and a two-hundred day moving average price of $1.05.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.07) earnings per share for the quarter, meeting the consensus estimate of ($0.07). Curaleaf had a negative net margin of 17.37% and a negative return on equity of 14.12%. Analysts forecast that Curaleaf Holdings, Inc. will post -0.25 EPS for the current year.

Curaleaf Company Profile

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

Read More

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines